JIC RELEASE NO. 1148 - Cumulative COVID-19 Test Results: 48 New Cases Reported October 18–24, Five Hospitalized; Additional COVID-19 Updates

Cumulative COVID-19 Test Results: 48 New Cases Reported October 18–24

Today, the Department of Public Health and Social Services (DPHSS) reported 48 new cases of COVID-19 from 1,812 specimens analyzed from tests administered October 17–23, 2022:

• October 24: 8 of 181 test positive for COVID-19

• October 23: 2 of 150 test positive for COVID-19

• October 22: 9 of 201 test positive for COVID-19

• October 21: 15 of 236 test positive for COVID-19

• October 20: 6 of 295 test positive for COVID-19

• October 19: 4 of 264 test positive for COVID-19

• October 18: 4 of 485 test positive for COVID-19

To date, there have been a total of 58,751 officially reported cases, 401 deaths, 46 cases in active isolation, and 58,304 not in active isolation.

Five Hospitalized for COVID-19

COVID-19 Community Testing at Tiyan Ended; COVID-19 Testing Available at The Plaza Shopping Center

The drive-through COVID-19 testing at Tiyan is no longer available. Residents may seek free COVID-19 testing at The Plaza Shopping Center in the Dusit Beach Resort from 9 a.m. to 12 p.m. and 2 p.m. to 4 p.m,  Monday through Saturday. Those who need ADA accommodations for curbside testing in their vehicles may call 671-998-4530. No symptoms are needed for COVID-19 testing at The Plaza Shopping Center.

Bivalent Boosters Available at DPHSS Vaccination Clinics

On October 12, 2022, the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) recommended the use of new bivalent formulations of Pfizer-BioNTech and Moderna mRNA COVID-19 vaccines as a booster dose.

A single booster dose of bivalent Pfizer-BioNTech COVID-19 Vaccine (for individuals age 5 years and older) or bivalent Moderna COVID-19 Vaccine (for individuals age 6 years and older) may be given at least 2 months after completion of a monovalent primary series or any prior monovalent booster dose of COVID-19 vaccine. At this time, there is no change to the monovalent vaccine schedules for children age 6 months through 4 years. Monovalent mRNA vaccines are no longer authorized as a booster dose for people ages 5 years and older. People must first complete at least a primary series with the original monovalent vaccine before receiving a single bivalent booster at least 2 months later.

• People may receive either brand of bivalent vaccine that is age-appropriate; there is no preference and no need to match the brand of the primary series.

• This recommendation is for a one-time booster. ACIP does not anticipate recommendations for frequent (e.g., every few months) booster doses of bivalent vaccine.  

• COVID-19 vaccines may be co-administered with all other routinely recommended vaccines, including influenza vaccine.

The updated Pfizer BioNTech and Moderna bivalent boosters are available at the DPHSS vaccination clinics at The Plaza Shopping Center, NRCHC, SRCHC, and our extended outreach vaccination events.
 

Novavax COVID-19 Vaccine Available at Northern and Southern Region Community Health Centers

On October 11, DPHSS received an additional 200 doses of the Novavax COVID-19 vaccine. The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization for the Novavax vaccine on July 13. According to the CDC, the Novavax vaccine is a two-dose adjuvanted vaccine that is administered intramuscularly in deltoid muscle in adults 18 years of age or older. The Novavax vaccine is a two-dose primary series with three to eight weeks between dose one and dose two. Currently, the Novavax vaccine is not authorized for any booster dose. Additionally, individuals who complete their primary series with two doses of Novavax vaccine are not eligible for a booster dose at this time. The Novavax vaccine is only available at the DPHSS Community Health Centers in Dededo and Inalåhan.

DPHSS mAb Treatment Center Open at Paseo Stadium

Bebtelovimab, a monoclonal antibody (mAb) for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms) is available at the DPHSS mAb treatment center at the Paseo Stadium in Hagåtña from 9 a.m. to 4 p.m., and closes for lunch from 12 p.m. to 1 p.m., Monday through Saturday. 

To schedule treatment at the DPHSS mAb treatment center, patients must call 671-998-4527 or 671-998-4547, have a current, laboratory confirmed COVID–19 infection and a referral from a prescribing physician. For more information about Bebtelovimab and other mAb treatment options on Guam, visit dphss.guam.gov/mab or dial 311 from a local number and select option 1 on weekdays from 8 a.m. to 9 p.m. and on weekends and holidays from 8 a.m. to 5 p.m. 

COVID-19 Vaccines for Children 6 Months and Older Available at DPHSS CHCs

The Moderna and the Pfizer-BioNTech COVID-19 Vaccines are authorized for use in children from six months of age and older. In most children, the Moderna COVID-19 vaccine for children ages six months through five years will be a two-dose primary series with four to eight weeks between dose one and dose two. In most children, the Pfizer-BioNTech COVID-19 vaccine for children ages six months through four years will be a three-dose primary series three to eight weeks between dose one and dose two, and at least eight weeks between dose two and dose three. Requirements for minors to receive the Moderna or Pfizer-BioNTech COVID-19 Vaccine at DPHSS vaccination clinics and outreach events:

• Parent/legal guardian must provide minor’s birth certificate

• Parent/legal guardian must have a government-issued photo identification

• Minor must be accompanied by a parent or legal guardian

• Guardians must present legal guardianship or power-of-attorney documents

Guam COVID-19 Vaccination Update – As of October 24, 2022

As of October 24, 2022, 140,332 eligible residents (6 months and older) are fully vaccinated. This total includes 14,161 residents 12 – 17 years old. 9,164 residents 5 – 11 years old received their first dose of a two dose series. 7,538 residents 5 – 11 years old have completed their two-dose series. 262 residents 6 months – 5 years old have received their first dose of a two dose series. 82,807 eligible residents have received their first booster shots. 12,990 eligible residents have received their second booster shots.